Coherus Biosciences | SCHULD



Debt Veränderung Datum
AbbVie USD 67.14B 3.94B 2024-12
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
Baxter International USD 13.13B 191M 2024-12
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Fujifilm JPY 685.91B 59.58B 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 34.84B 2.27B 2025-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 583.38M 1.94M 2025-03
Perrigo USD 3.63B 9.4M 2025-03
Pfizer USD 62.11B 2.24B 2025-03
PTC Therapeutics USD 2.4B 17.29M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Teva Pharmaceutical Industries USD 16.65B 1.43B 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 154.38M 9.23M 2025-03
Zoetis USD 6.58B 7M 2025-03



Coherus Biosciences SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.